Congratulations! Dr. Hamed Najafabadi named the Alfred P. Sloan Research Fellow

24-August-12

Source: McGill Newsroom

Hamed Najafabadi, an assistant professor in McGill’s Department of Human Genetics, and Stuart Trenholm, assistant professor at the Montreal Neurological Institute, have been selected as 2018 Alfred P. Sloan Research Fellows – a coveted distinction awarded to highly promising early-career scientists from the United States and Canada. Past recipients include towering figures in the history of science, such as physicists Richard Feynman and Murray Gell-Mann and game theorist John Nash. Forty-five fellows have received a Nobel Prize in their respective field.

The fellowships are open to scholars in eight scientific and technical fields: chemistry, computer science, economics, mathematics, computational and evolutionary molecular biology, neuroscience, ocean sciences, and physics. Candidates must be nominated by their fellow scientists and winning fellows are selected by an independent panel of senior scholars on the basis of a candidate’s research accomplishments, creativity, and potential to become a leader in his or her field. Winners receive a two-year, $65,000 fellowship to further their research.

The Sloan Foundation announced this year’s Fellows on www.sloan.org and in an advertisement in the New York Times on Feb. 15.

A look at McGill’s two new Sloan Research Fellows and their work:

[Read More]

__________________________________

Epigenetic alteration of a vitamin B12 gene shines new light on our understanding of rare diseases

Reported by EurekAlert and AAAS on Jan 30, 2018  

Rare hereditary recessive diseases were thought to be expressed in off-spring only when both parents carry a mutation in the causal gene, but a new study is changing this paradigm. An international research team led by scientists at the University of Lorraine in France along with McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) in Canada discovered a new cause of a rare condition known as cblC, that they named “epi-cblC”. They reported it in patients from Europe and the United States. Patients who have cblC are not able to process *vitamin B12, leading to severe health problems.

[Read More]

__________________________________

Lung cancer: the numbers don’t lie

Fact: according to statistics from the Canadian Cancer Society, lung cancer is the leading cause of death from cancer for both men and women in Canada. That’s why this month, the Goodman Cancer Research Centre – as part of a new video series – is highlighting lung cancer, and the work of Dr. Logan Walsh, Assistant Professor in the Department of Human Genetics.

[Read More]

__________________________________

Comments are closed.